Summary of Key Information:
Reporting Period (Quarter/Year): Quarter ended 30th June, 2026 (Q1 FY27)
Nature of Filing / Announcement: Outcome of Board Meeting - Financial Results and Corporate Decisions
Audit Opinion:
Clean opinion - Limited Review Report by Statutory Auditors S N Dhawan & CO LLP stated no material misstatements were found in the unaudited financial results.
Key Financial Highlights [Rs in crore]:
Standalone Results:
Revenue from Operations: ₹406.15 crore (Q1 FY27) vs ₹365.06 crore (Q1 FY26) - 11.3% YoY growth
Total Income: ₹414.57 crore (Q1 FY27) vs ₹371.96 crore (Q1 FY26)
Net Profit: ₹55.85 crore (Q1 FY27) vs ₹51.46 crore (Q1 FY26) - 8.5% YoY growth
EPS: ₹6.09 (Q1 FY27) vs ₹5.61 (Q1 FY26)
Expense Breakdown:
Cost of materials consumed: ₹70.13 crore
Employee benefits expense: ₹72.96 crore
Professional charges to doctors: ₹111.15 crore
Finance costs: ₹1.65 crore
Depreciation and amortization expense: ₹11.76 crore
Other expenses: ₹72.10 crore
Total expenses: ₹339.75 crore
Tax Details:
Current Tax: ₹19.68 crore
Deferred Tax: (₹0.71) crore
Other Comprehensive Income:
Net of tax expenses: ₹2.25 crore
Total comprehensive income: ₹58.10 crore
Capital Structure:
Paid-up equity share capital: ₹91.67 crore (Face value ₹10 each)
Reserves (excluding Revaluation Reserves) as of previous year: ₹648.70 crore
Segment-wise Performance:
The Company operates in a single segment i.e. Healthcare and hence, does not have any additional disclosures to be made under Ind AS 108 on Operating Segments.
Corporate Actions:
Dividend: Record date fixed as Friday, 18th September, 2026 for determining shareholders entitled to dividend for year 2025-26
Other Significant Information:
Entities included/excluded in consolidation: The Company does not have any subsidiary/associate/joint venture company(ies), as on 30th June, 2026
Annual General Meeting: 38th AGM scheduled for Thursday, 24th September, 2026 through video conferencing/other audio-visual means